Quintiles

Quintiles Expands Phase I Capacity in London

Thursday, March 11, 2010 07:38 AM

Quintiles expanded its London-based phase I facility by 35 beds, bringing the total number of phase I beds in London to 105 and globally to 385. The CRO said this number will increase even further later this year as a result of the planned opening of a phase I unit in Hyderabad, India. That facility will initially have 50 beds with capacity for 100.

More... »

INC Research Launches Alliance Partnerships Program

Wednesday, February 24, 2010 06:45 AM

Raleigh, N.C.-based CRO INC Research launched an alliance partnerships program to create and manage strategic alliances with pharmaceutical and biotech customers. The company said it hopes to create relationships with customers based on joint strategic objectives rather than service agreements.

More... »

Quintiles Adds Anatomic Pathology Services to China Lab

Tuesday, February 23, 2010 07:49 AM

Quintiles added anatomic pathology to the service offerings it provides at its central laboratory in Beijing, China. The new services complement assay development, digital pathology and core lab offerings, which the Beijing facility already offers to help customers comply with China’s restrictions on tissue import and export.

More... »

Quintiles Partners with Belgium Pharma Movetis in Commercialization Deal

Tuesday, February 2, 2010 06:50 AM

Quintiles has entered into a strategic alliance with Movetis to help sell the Belgium pharma company’s new gastrointestinal product.

More... »

Quintiles Rebrands with ‘New Health’

Monday, January 25, 2010 09:05 AM

Quintiles launched a new brand identity this morning, focused on what the contract research organization (CRO) is calling “The New Health”—the rapidly changing world of biopharma.

More... »

Quintiles in Alliances with AstraZeneca, Eisai

Wednesday, November 4, 2009 07:21 AM

Quintiles has entered into a strategic alliance with AstraZeneca. The contract research organization (CRO)-clinical pharmacology alliance with AstraZeneca was formed to deliver the sponsor’s clinical pharmacology studies across multiple therapy areas and around the globe.

More... »

Quintiles, Cerner Join to Improve Late Phase Research Efficiency

Friday, October 16, 2009 08:11 AM

Quintiles, the market-leading contract research organization (CRO) and Cerner, a global supplier of healthcare solutions and electronic health record (EHR) technology, signed an agreement that will provide biopharmaceutical sponsors with research and technology services for improving post-marketing research. 

More... »

Sage Bionetworks Receives Quintiles Donation

Wednesday, October 14, 2009 07:41 AM

Sage Bionetworks, a not-for-profit organization established to develop an open-access genomic platform for use in drug discovery, has received a major donation from Quintiles, a contract research organization (CRO).

More... »

Quintiles Expands with New Facility in Scotland

Monday, October 5, 2009 09:55 AM

Quintiles has boosted its capacity to support clinical trials across Europe by opening an expanded regional facility, including an 80,000-square-foot central laboratory, near Edinburgh, Scotland. 

More... »

Quintiles Aims to Increase Patient Enrollment through South Africa Partnership

Monday, September 28, 2009 06:06 AM

Quintiles added another partner to its Prime Site program—an initiative to accelerate drug development and gain access to more patients.

More... »